71002-88-5

Basic information

• Product Name: 4-(5-nitro-H-benzimidazol-2-yl)aniline
• Synonyms: 4-(5-nitro-H-benzimidazol-2-yl)aniline;4-(5-Nitro-1H-benzimidazol-2-yl)aniline;4-(5-Nitrobenzimidazol-2-yl)aniline;4-(5-nitro-1H-1,3-benzodiazol-2-yl)aniline;4-(5-nitro-1H-benzo[d]imidazol-2-yl)aniline;4-(6-nitro-1H-benzimidazol-2-yl)Benzenamine
• CAS NO: 71002-88-5
• Molecular Formula: C₁₃H₁₀N₄O₂
• Molecular Weight: 254.2441
• EINECS: 275-115-4
• Mol File: 71002-88-5.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 551.3 °C at 760 mmHg
• Flash Point: 287.2 °C
• Appearance: /
• Density: 1.456 g/cm³
• Vapor Pressure: 3.37E-12mmHg at 25°C
• Refractive Index: 1.762
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• CAS DataBase Reference: 4-(5-nitro-H-benzimidazol-2-yl)aniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(5-nitro-H-benzimidazol-2-yl)aniline(71002-88-5)
• EPA Substance Registry System: 4-(5-nitro-H-benzimidazol-2-yl)aniline(71002-88-5)

Safety Data

• Hazardous Substances Data: 71002-88-5(Hazardous Substances Data)

Usage

General Description

4-(5-Nitro-H-benzimidazol-2-yl)aniline is a chemical compound with a complex structure that includes a benzimidazole ring system. The benzimidazole moiety is often found in therapeutic drugs and has extensive pharmaceutical applications. The nitro group and the aniline group offer potential for chemical reactions. However, detailed specific information such as the physical and chemical properties, toxicity, reactivity, or uses of this specific compound isn't widely available in public databases, suggesting that it may not be studied extensively. Therefore, potential applications or risks of 4-(5-Nitro-H-benzimidazol-2-yl)aniline are not well-known and may need further investigation.

InChI:InChI=1/C13H10N4O2/c14-9-3-1-8(2-4-9)13-15-11-6-5-10(17(18)19)7-12(11)16-13/h1-7H,14H2,(H,15,16)

Upstream product

• 2963-77-1 4-(1H-benzimidazol-2-yl)aniline 
• 556-18-3 4-aminobenzaldehyde 
• 99-56-9 4-Nitrophenylene-1,2-diamine 
• 555-16-8 4-nitrobenzaldehdye 
• 150-13-0 4-amino-benzoic acid 
• 122-85-0 para-acetamidobenzaldehyde 
• 745809-88-5 2-(4-p-acetaminophenyl)-5⁽⁶⁾-nitrobenzimidazole 
• 1772-39-0 6-nitro-2-(4-nitrophenyl)-1H-benzo[d]imidazole 
• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 

Downstream Products

• 1027202-86-3 4-methyl-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1027223-37-5 4-chloro-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1027429-74-8 4-methoxy-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1027566-16-0 biphenyl-4-carboxylic acid [4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-amide 
• 331851-68-4 4-nitro-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1026869-62-4 3,4-dichloro-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1027504-31-9 2,4-dichloro-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1026245-95-3 4-bromo-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1027290-74-9 2,6-dichloro-N-[4-(5-nitro-1H-benzoimidazol-2-yl)-phenyl]-benzamide 
• 1246470-90-5 C₂₃H₂₅N₅O₅ 
• 87353-68-2 N,N'-Bis<2-(4-trifluoroacetamidophenyl)benzimidazol-5-yl>terephthaloyl diamide 
• 87345-65-1 N,N'-Bis<2-(4-aminophenyl)benzimidazol-5-yl>terephthaloyl diamide 

Relevant articles and documents

Experimental and theoretical investigation of long-wavelength fluorescence emission in push-pull benzazoles: Intramolecular proton transfer or charge transfer in the excited state?

This study presents the synthesis, characterisation and theoretical calculations of compounds that contain electron donor and withdrawing groups connected through a π-conjugated benzazolic structure. The compounds in solution show an absorption maximum in the UV-visible spectrum (380-390 nm) due to spin and symmetry allowed electronic 1ππ? transitions with no clear evidence for charge transfer in either compound in the ground state. A fluorescence emission located in the violet-blue-green region, tailored by solvent polarity, with a large Stokes shift was observed. Taking the long-wavelength emission into account, the Lippert-Mataga plot indicates a positive solvatochromism in the solvent polarity function (Δf) range 0.02-0.20, related to the occurrence of an ICT mechanism in the excited state. At Δf greater than 0.20, the polarity of the medium seems no longer to increase the stabilization of the compounds, reaching a plateau. Time-dependent density functional theory (TD-DFT) and resolution-of-identity second-order approximate coupled-cluster (RI-CC2) calculations were also used to better understand the excited state of these compounds. The results indicated that ESIPT was disfavoured in the compounds, mainly in polar solvents, and the emission wavelengths were primarily associated with ICT. In summary, in these push-pull compounds, the electron donating and withdrawing groups do not favour the ESIPT process.

BENZIMIDAZOLE DERIVATIVES FOR DNA METHYLATION INHIBITORS

The invention provides for DNA methylation inhibitors, and also methods and use of the compounds of the invention, by themselves or in combination with other therapies, for treating a disease in which DNA hypermethylation is found.

INHIBITORS OF HEPATITIS C VIRUS REPLICATION

The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5A inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5A activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.